
Telmicap AH 40mg/5mg/12.5mg Tablet
Marketer
Cappeline Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmicap AH 40mg/5mg/12.5mg Tablet
Hypertensive patients whose condition isn't controlled by a single medication may benefit from Telmicap AH 40mg/5mg/12.5mg tablets. This triple-combination therapy effectively reduces elevated blood pressure, thereby lowering the risk of stroke and myocardial infarction. Administration is independent of meals, with dosage individualized based on patient response and overall health. Consistent daily dosing is crucial for optimal efficacy. Continue treatment as directed by your physician; discontinuation may increase cardiovascular event risk. The formulation includes a diuretic, potentially increasing urination; therefore, avoid evening doses within four hours of bedtime. Regular use, even during asymptomatic periods (as hypertension often lacks obvious symptoms), is essential. Common side effects include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential side effects like dry mouth, thirst, and muscle weakness. Prior to starting this medication, disclose any kidney or liver impairments to your physician. Pregnant or lactating individuals should seek medical advice before use. Inform your doctor of all other medications, particularly those for heart or blood pressure management. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to ensure treatment effectiveness.
Uses of Telmicap AH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Telmicap AH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 40mg/5mg/12.5mg Telmicap AH tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Telmicap AH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmicap AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Telmicap AH 40mg/5mg/12.5mg Tablet can be consumed with or without food, though consistent daily timing is recommended.
How Telmicap AH 40mg/5mg/12.5mg Tablet works:
Each Telmicap AH 40mg/5mg/12.5mg tablet unites telmisartan (an angiotensin receptor blocker or ARB), amlodipine (a calcium channel blocker or CCB), and hydrochlorothiazide (a diuretic). Telmisartan and amlodipine reduce blood pressure by promoting vasodilation, widening and relaxing blood vessels. Hydrochlorothiazide lowers blood pressure by increasing urine production, eliminating excess fluid and electrolytes, and contributing to vasodilation over time, improving circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmicap AH 40mg/5mg/12.5mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Telmicap AH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Telmicap AH 40mg/5mg/12.5mg tablets while breastfeeding poses a safety risk. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telmicap AH 40mg/5mg/12.5mg Tablets. These tablets can cause dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmicap AH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; professional medical advice is recommended. Telmicap AH 40mg/5mg/12.5mg tablets are not advised for those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Telmicap AH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is recommended.
What if you forget to take Telmicap AH 40mg/5mg/12.5mg Tablet :
Should you forget to take a Telmicap AH 40mg/5mg/12.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Telmicap AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | HEART |
